Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1495-1508

  Hasnie, F S ^a   Breuer, J ^b   Parker, S ^b   Wallace, V ^a   Blackbeard, J ^a   Lever, I ^a   Kinchington, P R ^c   Dickenson, A H ^d   Pheby, T ^a   Rice, A S C ^a  

^a Faculty of Medicine   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

analgesia; anxiety like behavior; neuropathy; open field; postherpetic neuralgia; zoster associated pain

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; CANNABINOID; DIMETHYL SULFOXIDE; GABAPENTIN; IBUPROFEN; MORPHINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; COMORBIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SCREENING; FIBROBLAST; FOOT PAD; GLABROUS SKIN; HERPES ZOSTER; HINDLIMB; HYPERSENSITIVITY; MALE; MECHANICAL HYPERSENSITIVITY; MECHANICAL STIMULATION; MOBILIZATION; NOCICEPTION; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; VARICELLA ZOSTER VIRUS; VIRUS CONCENTRATION; VIRUS CULTURE; VIRUS STRAIN; WISTAR RAT; WITHDRAWAL REFLEX; ZOSTER ASSOCIATED PAIN;

AMINES; ANALGESICS; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CELLS, CULTURED; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; FIBROBLASTS; GAMMA-AMINOBUTYRIC ACID; HERPESVIRUS 3, HUMAN; HYPERALGESIA; MALE; MOTOR ACTIVITY; NEURALGIA, POSTHERPETIC; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVES; PHYSICAL STIMULATION; RATS; RATS, WISTAR; VIRAL LOAD;

EID: 33846369794     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.11.029     Document Type: Article

References (49)

1. Abendroth A., and Arvin A.M. Immune evasion as a pathogenic mechanism of varicella zoster virus. Semin Immunol 13 (2001) 27-39
2. Back S.K., Won S.Y., Hong S.K., and Na H.S. Gabapentin relieves mechanical, warm and cold allodynia in a rat model of peripheral neuropathy. Neurosci Lett 368 (2004) 341-344
3. Belzung C., and Dubreuil D. Naloxone potentiates the anxiolytic but not the amnesic action of chlordiazepoxide in C57BL/6 mice. Behav Pharmacol 9 (1998) 691-698
4. Biron K.K., Noblin J.E., de Miranda P., and Elion G.B. Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice. Antimicrob Agents Chemother 21 (1982) 44-50
5. Bonabello A., Galmozzi M.R., Canaparo R., Isaia G.C., Serpe L., Muntoni E., and Zara G.P. Dexibuprofen (S+-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents. Anesth Analg 97 (2003) 402-408
6. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population. Eur J Pain 3 (1999) 335-342
7. Bridges D., Ahmad K., and Rice A.S.C. The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol 133 (2001) 586-594
8. Bruggeman C.A., Engels W., and Endert J. Treatment of experimental cytomegalovirus infections with acyclovir. Arch Virol 97 (1987) 27-35
9. Coen P.G., Scott F., Leedham-Green M., Nia T., Jamil A., Johnson R.W., and Breuer J. Predicting and preventing post-herpetic neuralgia: Are current risk factors useful in clinical practice. Eur J Pain 10 (2006) 695-700
10. Cryan J.F., and Holmes A. Model organisms: The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4 (2005) 775-790
11. Dalziel R.G., Bingham S., Sutton D., Grant D., Champion J.M., Dennis S.A., Quinn J.P., Bountra C., and Mark M.A. Allodynia in rats infected with varicella zoster virus-a small animal model for post-herpetic neuralgia. Brain Res Brain Res Rev 46 (2004) 234-242
12. Davison A.J., and Scott J.E. The complete DNA sequence of varicella-zoster virus. J Gen Virol 67 (1986) 1759-1816
13. Decosterd I., Allchorne A., and Woolf C.J. Differential analgesic sensitivity of two distinct neuropathic pain models. Anesth Analg 99 (2004) 457-463
14. de-Paris F., Busnello J.V., Vianna M.R., Salgueiro J.B., Quevedo J., Izquierdo I., and Kapczinski F. The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats. Behav Pharmacol 11 (2000) 169-173
15. Dubinsky R.M., Kabbani H., El-Chami Z., Boutwell C., and Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63 (2004) 959-965
16. Dworkin R.H., and Portenoy R.K. Proposed classification of herpes zoster pain. Lancet 343 (1994) 1648
17. Field M.J., Bramwell S., Hughes J., and Singh L. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?. Pain 83 (1999) 303-311
18. Fields H.L., Rowbotham M., and Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 5 (1998) 209-227
19. Fleetwood-Walker S.M., Quinn J.P., Wallace C., Blackburn-Munro G., Kelly B.G., Fiskerstrand C.E., Nash A.A., and Dalziel R.G. Behavioural changes in the rat following infection with varicella-zoster virus. J Gen Virol 80 (1999) 2433-2436
20. Garry E.M., Delaney A., Anderson H.A., Sirinathsinghji E.C., Clapp R.H., Martin W.J., Kinchington P.R., Krah D.L., Abbadie C., and Fleetwood-Walker S.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118 (2005) 97-111
21. Hempenstall K., Nurmikko T.J., Johnson R.W., A'Hern R.P., and Rice A.S.C. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2 (2005) 0628-0644
22. Johnson R., and Patrick D. Improving the management of varicella, herpes zoster and zoster-associated pain (2003). http://www.ihmf.org/library/lib_mon.asp Online resource available at http://www.ihmf.org/library/lib_mon.asp
23. Kennedy P.G. Key issues in varicella-zoster virus latency. J Neurovirol 8 (2002) 80-84
24. Kennedy P.G. Varicella-zoster virus latency in human ganglia. Rev Med Virol 12 (2002) 327-334
25. Kennedy P.G., Grinfeld E., and Gow J.W. Latent varicella-zoster virus in human dorsal root ganglia. Virology 258 (1999) 451-454
26. Kennedy P.G., Grinfeld E., and Gow J.W. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 95 (1998) 4658-4662
27. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
28. Kinchington P.R. Latency of varicella zoster virus: a persistently perplexing state. Front Biosci 4 (1999) 200-211
29. Kontinen V.K., Kauppila T., Paananen S., Pertovaara A., and Kalso E. Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain 80 (1999) 341-346
30. Kontinen V.K., and Meert T.F. Predictive validity of neuropathic pain models in pharmacological studies with behavioural outcome in rat: a systematic review. Proceedings of the 10th World Congress on Pain 24 (2003) 489-498
31. LaBuda C.J., and Little P.J. Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 144 (2005) 175-181
32. Meyer-Rosberg K., Kvarnstrom A., Kinnman E., Gordh T., Nordfors L.O., and Kristofferson A. Peripheral neuropathic pain: a multidimensional burden for patients. Eur J Pain 5 (2001) 379-389
33. Mitchell B.M., Bloom D.C., Cohrs R.J., Gilden D.H., and Kennedy P.G. Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 9 (2003) 194-204
34. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., and Arvin A.M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72 (1998) 965-974
35. Mogil J.S., and Crager S.E. What should we be measuring in behavioral studies of chronic pain in animals?. Pain 112 (2004) 12-15
36. Myers M.G., and Connelly B.L. Animal models of varicella. J Infect Dis 166 (1992) 48-50
37. Myers M.G., Stanberry L.R., and Edmond B.J. Varicella-zoster virus infection of strain 2 guinea pigs. J Infect Dis 151 (1985) 106-113
38. Narita M., Kaneko C., Miyoshi K., Nagumo Y., Kuzumaki N., Nakajima M., Nanjo K., Matsuzawa K., Yamazaki M., and Suzuki T. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31 (2006) 739-750
39. Nicholson B., and Verma S. Comorbidities in chronic neuropathic pain. Pain Med 5 (2004) 9-27
40. Nurmikko T. Clinical features and pathophysiologic mechanisms of postherpetic neuralgia. Neurology 45 (1995) 54-55
41. Pappagallo M., Oaklander A.L., Quatrano-Piacentini A.L., Clark M.R., and Raja S.N. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology 92 (2000) 691-698
42. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 (2003) 3-33
43. Rog D.J., Nurmikko T.J., Friede T., and Young C.A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65 (2005) 812-819
44. Rowbotham M.C., and Fields H.L. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 119 (1996) 347-354
45. Sadzot-Delvaux C., Merville-Louis M.P., Delree P., Marc P., Piette J., Moonen G., and Rentier B. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res 26 (1990) 83-89
46. Schafers M., Marziniak M., Sorkin L.S., Yaksh T.L., and Sommer C. Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol 185 (2004) 160-168
47. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
48. Surman O.S., Flynn T., Schooley R.T., Baer L., Parker S., Hirsch M.S., and Davis L.G. A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics 31 (1990) 287-292
49. Vissers K., Hoffmann V., Geenen F., Biermans R., and Meert T. Is the second phase of the formalin test useful to predict activity in chronic constriction injury models?. A pharmacological comparison in different species. Pain Practice 3 (2003) 298-309